Does ARIPIPRAZOLE Cause Interstitial lung disease? 42 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 42 reports of Interstitial lung disease have been filed in association with ARIPIPRAZOLE (Aripiprazole). This represents 0.1% of all adverse event reports for ARIPIPRAZOLE.
42
Reports of Interstitial lung disease with ARIPIPRAZOLE
0.1%
of all ARIPIPRAZOLE reports
4
Deaths
29
Hospitalizations
How Dangerous Is Interstitial lung disease From ARIPIPRAZOLE?
Of the 42 reports, 4 (9.5%) resulted in death, 29 (69.0%) required hospitalization, and 1 (2.4%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ARIPIPRAZOLE. However, 42 reports have been filed with the FAERS database.
What Other Side Effects Does ARIPIPRAZOLE Cause?
Drug ineffective (5,566)
Off label use (5,473)
Product use in unapproved indication (4,792)
Weight increased (4,636)
Anxiety (3,076)
Suicide attempt (2,796)
Suicidal ideation (2,618)
Condition aggravated (2,157)
Insomnia (2,147)
Akathisia (2,107)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which ARIPIPRAZOLE Alternatives Have Lower Interstitial lung disease Risk?
ARIPIPRAZOLE vs ARIPIPRAZOLE LAUROXIL
ARIPIPRAZOLE vs ARIXTRA
ARIPIPRAZOLE vs ARMODAFINIL
ARIPIPRAZOLE vs AROMASIN
ARIPIPRAZOLE vs ARSENIC TRIOXIDE